Paeds SAQs · growth-development-and-behaviour
Cerebral palsy surveillance and multidisciplinary management — formative SAQs
Two formative SAQs on GMFCS-linked hip surveillance, functional classification, tone pathways and medical-home coordination in cerebral palsy.
On this page & tools
Target exams
SAQ 1 — Classification and hip surveillance (10 marks)
A 6-year-old with bilateral spastic cerebral palsy is GMFCS IV. The parent asks why “another hip X-ray” is needed when the child is not complaining of pain. No orthopaedic appointment is booked. [3] [8] [10]
Questions
- Define cerebral palsy in one consensus sentence and name three classification layers you will state in a viva. (3 marks) [1] [3]
- Explain why hip surveillance intensity rises with GMFCS and what population programmes have shown. (4 marks) [8] [9]
- Outline three actions that close the loop after today’s visit. (3 marks) [10] [18]
Model answer
Definition and layers (3). Cerebral palsy is a permanent disorder of movement and posture causing activity limitation, attributed to non-progressive disturbances in the developing fetal or infant brain, often with associated sensory, cognitive, communication, behavioural, epilepsy and secondary musculoskeletal problems. State motor type, topography and GMFCS (add MACS/CFCS/EDACS when relevant). [1] [3]
Hip risk and programmes (4). Hip displacement risk increases as GMFCS level rises; non-ambulant children (especially IV–V) are highest risk and may be asymptomatic until late. Population surveillance with timely surgery (Hägglund) reduces dislocation. Australian hip surveillance guidelines stratify radiographic follow-up by GMFCS and age — absence of pain does not cancel surveillance. [8] [9] [10]
Close the loop (3). Obtain or schedule the indicated radiograph; name an owner and review date; refer orthopaedics if migration or exam is deteriorating; update the medical-home problem list and safety-net new pain or reduced abduction. [10] [18]
SAQ 2 — Tone, evidence and coordination (10 marks)
A. A registrar plans “botulinum toxin for whole-body tone” in mixed dystonia-spasticity without goals. B. Therapy is passive stretching only. C. The family has five uncoordinated specialist letters. [13] [17] [18]
Questions
- Distinguish spasticity from dystonia for management choice. (3 marks) [17]
- State the Novak traffic-light principle for choosing therapies. (3 marks) [13]
- Describe a medical-home coordination response to fragmented care. (4 marks) [18]
Model answer
Tone distinction (3). Spasticity is velocity-dependent resistance to passive stretch; dystonia is fluctuating involuntary posturing often triggered by intention or emotion. Wrongly treating dystonia as pure spasticity leads to ineffective or sedating escalation; use specialist dystonia pathways when dystonia dominates. [17]
Evidence lights (3). Prefer green-light goal-directed and activity-based interventions that train real tasks; many passive or non-specific modalities are yellow or red. Botulinum toxin is for focal functional goals within protocol, not “whole-body tone” without targets. [13]
Medical home (4). Create one shared problem list and goal list; assign owners for hips, tone, epilepsy, therapy and school; schedule review of open referrals; communicate a single plan to family and teams; start transition planning when age-appropriate. [18]
References
- [1]Rosenbaum P A report: the definition and classification of cerebral palsy April 2006. Developmental medicine and child neurology. Supplement, 2007.PMID 17370477
- [3]Palisano R Development and reliability of a system to classify gross motor function in children with cerebral palsy. Developmental medicine and child neurology, 1997.PMID 9183258
- [8]Soo B Hip displacement in cerebral palsy. The Journal of bone and joint surgery. American volume, 2006.PMID 16391257
- [9]Hägglund G Prevention of dislocation of the hip in children with cerebral palsy: 20-year results of a population-based prevention programme. The bone & joint journal, 2014.PMID 25371472
- [10]Wynter M Australian hip surveillance guidelines for children with cerebral palsy: 5-year review. Developmental medicine and child neurology, 2015.PMID 25846730
- [13]Novak I State of the Evidence Traffic Lights 2019: Systematic Review of Interventions for Preventing and Treating Children with Cerebral Palsy. Current neurology and neuroscience reports, 2020.PMID 32086598
- [17]Fehlings D Pharmacological and neurosurgical interventions for managing dystonia in cerebral palsy: a systematic review. Developmental medicine and child neurology, 2018.PMID 29405267
- [18]Liptak GS Providing a primary care medical home for children and youth with cerebral palsy. Pediatrics, 2011.PMID 22042817